Enable job alerts via email!
A leading global biopharma company in London is seeking a Director of Clinical Sciences, Oncology. This role involves developing and leading oncology strategies, ensuring high-quality clinical trial designs, and driving components for regulatory submissions. Candidates should have an advanced degree and at least 5 years of relevant experience. Strong leadership and communication skills are essential for success in this position.
Social network you want to login/join with:
col-narrow-left
GSK
London, United Kingdom
Other
-
Yes
col-narrow-right
b5f0a4f56a0e
8
12.08.2025
26.09.2025
col-wide
As the Director of Clinical Sciences, Oncology, you will be responsible for developing and leading GSK medium and long-term oncology development strategies for GSK’s oncology pipeline. You will work closely within a matrix organization to ensure that the oncology clinical team have the highest quality capabilities and expertise. You will also ensure the optimal launch of new products and appropriate optimal patient use of currently available GSK Medicines through leadership and collaboration.
Please note: This position requires an on-site office -based presence 2 to 3 days a week in the Waltham- MA.; UK (London or Stevenage); Upper Providence- PA.; Switzerland (Zug); or Poland (Warsaw).
This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:
In this role you will:
Basic Qualifications:
We are looking for professionals with these required skills to achieve our goals:
Preferred Qualifications:
If you have the following characteristics, it would be a plus:
Please visit to learn more about the comprehensive benefits program GSK offers US employees.
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK.